Augmentation of Anticancer Drug Efficacy in Murine Hepatocellular Carcinoma Cells by a Peripherally Acting Competitive N-Methyl-d-aspartate (NMDA) Receptor Antagonist.

about

Augmentation of Anticancer Drug Efficacy in Murine Hepatocellular Carcinoma Cells by a Peripherally Acting Competitive N-Methyl-d-aspartate (NMDA) Receptor Antagonist.

Item

http://www.wikidata.org/entity/Q47330693

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Augmentation of Anticancer Dru ...... te (NMDA) Receptor Antagonist.

@en

Augmentation of Anticancer Dru ...... mpetitive N-Methyl-d-aspartate

@nl

type

Item

label

Augmentation of Anticancer Dru ...... te (NMDA) Receptor Antagonist.

@en

Augmentation of Anticancer Dru ...... mpetitive N-Methyl-d-aspartate

@nl

prefLabel

Augmentation of Anticancer Dru ...... te (NMDA) Receptor Antagonist.

@en

Augmentation of Anticancer Dru ...... mpetitive N-Methyl-d-aspartate

@nl

P1476

Augmentation of Anticancer Dru ...... te (NMDA) Receptor Antagonist.

@en

P2093

Aleksanteri Petsalo

http://www.w3.org/2001/XMLSchema#string

Ilaria Proietti Silvestri

http://www.w3.org/2001/XMLSchema#string

Jacob C Hansen

http://www.w3.org/2001/XMLSchema#string

Liwei Han

http://www.w3.org/2001/XMLSchema#string

Mikko Gynther

http://www.w3.org/2001/XMLSchema#string

Seppo Auriola

http://www.w3.org/2001/XMLSchema#string

Silke Kayser

http://www.w3.org/2001/XMLSchema#string

Yevheniia Ishchenko

http://www.w3.org/2001/XMLSchema#string

Younes Larsen

http://www.w3.org/2001/XMLSchema#string

P2860

Multidrug Resistance Proteins (MRPs) and Cancer Therapy

Structural Determinants of Agonist Efficacy at the Glutamate Binding Site of N-Methyl-D-Aspartate Receptors

Chemoenzymatic synthesis of new 2,4-syn-functionalized (S)-glutamate analogues and structure-activity relationship studies at ionotropic glutamate receptors and excitatory amino acid transporters

Structure-Activity Relationship Study of Ionotropic Glutamate Receptor Antagonist (2S,3R)-3-(3-Carboxyphenyl)pyrrolidine-2-carboxylic Acid

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases

Glutamate receptor ion channels: structure, regulation, and function

BCRP/ABCG2 inhibition sensitizes hepatocellular carcinoma cells to sorafenib

Regulation of multidrug resistance proteins by genistein in a hepatocarcinoma cell line: impact on sorafenib cytotoxicity

Cancer drug resistance: an evolving paradigm

P304

9885-9904

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACS.JMEDCHEM.7B01624

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29205034

http://www.w3.org/2001/XMLSchema#string

P932

5788303

http://www.w3.org/2001/XMLSchema#string